{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:04:36Z","timestamp":1767981876318,"version":"3.49.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSAMC"],"published-print":{"date-parts":[[2020,3,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Parkinsonism is a neurodegenerative disorder with a heavy disease burden,\ndespite the discovery and application of drugs. Current research is beginning to suggest the\npossible crucial roles of micronutrients such as pyridoxal phosphate in the prevention or management\nof neurodegenerative disorders.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>We investigated the possible protective effects of supplemental pyridoxal phosphate in\nChlorpromazine (CPZ)-induced Parkinsonism-like changes in mice.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Mice were assigned to eight groups of 30 mice each. Groups included Vehicle control\n(fed standard diet (SD), and administered intraperitoneal ip injection of saline and saline per\norem), levodopa-carbidopa (LD) group (SD, saline ip and LD per orem), two groups fed pyridoxal\nphosphate-supplemented diet (at 100 and 200 mg\/kg of feed), and administered saline both ip and\norally, CPZ group (SD, CPZ ip and saline per orem), CPZ\/LD group (SD, CPZ ip and LD per\norem) and finally two groups fed pyridoxal phosphate -supplemented diet (at 100 and 200 mg\/kg\nof feed) and administered CPZ ip plus saline per orem. Treatments were administered daily for a\nperiod of 21 days to allow for the induction of Parkinsonism features. Body weight and food intake\nwere measured weekly while neurobehavioural and biochemical tests were assessed at the end of\nthe experimental period.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Pyridoxal phosphate supplementation was associated with a reduction in CPZ-induced\nsuppression of open-field horizontal locomotion and rearing; and a significant increase in grooming\nactivity. Administration of pyridoxal phosphate-supplemented diet was also associated with\nimprovements in working-memory in CPZ-treated mice; and there was reduction in the index of\nanxiety and catalepsy score.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Pyridoxal phosphate supplementation was associated with significant benefits in\nCPZ-induced Parkinsonism-like changes in mice.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871524920666200120142508","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T04:57:41Z","timestamp":1580187461000},"page":"13-25","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["An Evaluation of the Effects of Pyridoxal Phosphate in Chlorpromazineinduced Parkinsonism using Mice"],"prefix":"10.2174","volume":"20","author":[{"given":"Anthony T.","family":"Olofinnade","sequence":"first","affiliation":[{"name":"Behavioural Neuroscience\/Neuropharmacology Unit, Department of Pharmacology, Ladoke Akintola University of Technology, Osogbo, Osun State, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolulope M.","family":"Onaolapo","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samad","family":"Oladimeji","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adetunji M.","family":"Fatoki","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Covenant I.","family":"Balogun","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-7050","authenticated-orcid":true,"given":"Adejoke Y.","family":"Onaolapo","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Ladoke Akintola University of Technology, Ogbomosho, Oyo State, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olakunle J.","family":"Onaolapo","sequence":"additional","affiliation":[{"name":"Behavioural Neuroscience\/Neuropharmacology Unit, Department of Pharmacology, Ladoke Akintola University of Technology, Osogbo, Osun State, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Central Nervous System Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/178450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T07:34:09Z","timestamp":1583307249000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/178450\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871524920666200120142508","relation":{},"ISSN":["1871-5249"],"issn-type":[{"value":"1871-5249","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-10-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}